Medanta Posts 34% Revenue Growth and Achieves Noida Hospital EBITDA Breakeven in Q2 FY27
Operating EBITDA rises 60% year-on-year to INR 3,701 million; Plans announced for new 500-bed hospital in Ghaziabad expanding Delhi NCR footprint
Medanta (Global Health Limited) achieved strong Q2 FY27 results with consolidated revenue from operations of INR 14,690 million, marking 34% year-on-year growth. Operating EBITDA rose 60% year-on-year to INR 3,701 million, with margin expansion to 25.2%. The Noida 550-bed hospital reached EBITDA breakeven within a year, supporting Medanta's expansion strategy including a new 500-bed hospital planned in Ghaziabad.
Global Health Limited
Earnings Call Transcript
Medanta reported robust financial and operational growth in Q2 FY27, with consolidated revenue from operations reaching INR 14,690 million, up 34% year-on-year. Operating EBITDA increased 60% to INR 3,701 million, with improved margins of 25.2%. The company's 550-bed hospital in Noida achieved EBITDA breakeven within a year, underscoring successful expansion and operating leverage.
The quarter saw a 30% increase in inpatient volumes and 38% growth in outpatient volumes across Medanta’s network, reflecting strong patient demand. Occupied bed days grew by 22% and network occupancy improved to 67% on expanded bed capacity.
Medanta’s total bed capacity rose by 17% year-on-year to 3,811 beds, with census capacity at 3,115 beds. Average revenue per patient increased by 3%. The company maintains a net cash surplus of INR 7,815 million as of September 30, 2026, supported by operating cash flows of INR 5,678 million for H1 FY27.
During the quarter, Medanta added advanced medical technologies including Siemens ARTIS icono biplane systems at Gurugram and cath lab and hip navigation systems at Patna. Over 100 doctors were onboarded, including 65 specialty clinicians.
A notable strategic move was the acquisition of a 2.61-acre land parcel in Ghaziabad to develop a new 500-bed multispecialty hospital, aiming to expand presence in Delhi NCR and serve a rapidly growing population. Medanta’s pipeline includes six new greenfield hospitals, targeting a doubling of bed capacity over time.
Highlights
- Q2 FY27 consolidated revenue from operations: INR 14,690 million, up 34% year-on-year.
- Operating EBITDA for Q2 FY27: INR 3,701 million, a 60% increase year-on-year; margins improved to 25.2%.
- Noida 550-bed hospital achieved EBITDA breakeven within one year post-inauguration.
- Patient volumes up: inpatient by 30%, outpatient by 38% year-on-year.
- Occupied bed days grew 22%; network occupancy increased to 67%.
- Total bed capacity increased to 3,811 beds, a 17% rise year-on-year; census beds at 3,115 beds in Q2 FY27 versus 2,658 beds a year earlier. Average revenue per patient rose 3%. Net cash surplus of INR 7,815 million as of September 30, 202
Key Data Snapshot
What happened
- Medanta reported consolidated revenue from operations of INR 14,690 million for Q2 FY27, a 34% increase year-on-year.
- Operating EBITDA rose 60% year-on-year to INR 3,701 million with margins expanding to 25.2%.
- The 550-bed Noida hospital reached EBITDA breakeven within a year of opening in November 2025.
- Patient volumes increased significantly, with inpatient up by 30% and outpatient by 38% year-on-year.
- Medanta maintained a net cash surplus of INR 7,815 million as of 30 September 2026.
Operational performance
- Network occupancy improved to 67% on expanded bed capacity from 64% a year earlier.
- Occupied bed days rose 22% year-on-year, supporting revenue growth.
- Average revenue per patient increased by 3% year-on-year.
- The total bed capacity grew 17% year-on-year to 3,811 beds, supporting volume growth.
- More than 100 new doctors, including 65 specialists, joined the network during the quarter.
- Advanced medical technologies including Siemens ARTIS icono biplane and hip navigation systems were added at key hospitals.
Strategic context
- Medanta acquired 2.61 acres in Ghaziabad to develop a 500-bed multispecialty hospital expanding its presence in Delhi NCR.
- The new hospital aims to serve Ghaziabad’s growing population with tertiary and quaternary care.
- Medanta’s expansion pipeline includes six new greenfield hospitals, targeting to double bed capacity over time.
- The company focuses on replicating the successful Medanta model of high-quality healthcare in new geographies.
- The Noida hospital’s breakeven milestone supports confidence in scale and operating leverage of this model.
Financial performance
- Q2 FY27 profit after tax was INR 2,191 million, up 38% year-on-year.
- Operating cash flows for H1 FY27 amounted to INR 5,678 million.
- Reporting refinements were introduced for improved transparency, with revenue reported as revenue from operations excluding other income, and operating EBITDA excluding other income and after ESOP expenses.
Highlights
- Q2 FY27 consolidated revenue from operations: INR 14,690 million, up 34% year-on-year.
- Operating EBITDA for Q2 FY27: INR 3,701 million, a 60% increase year-on-year; margins improved to 25.2%.
- Noida 550-bed hospital achieved EBITDA breakeven within one year post-inauguration.
- Patient volumes up: inpatient by 30%, outpatient by 38% year-on-year.
- Occupied bed days grew 22%; network occupancy increased to 67%.
- Total bed capacity increased to 3,811 beds, a 17% rise year-on-year; census beds at 3,115 beds in Q2 FY27 versus 2,658 beds a year earlier. Average revenue per patient rose 3%. Net cash surplus of INR 7,815 million as of September 30, 202
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source Information
More News on Earnings Call Transcript
View allLatest corporate announcements and market updates in Earnings Call Transcript.
Sunrakshakk Industries India Limited Posts INR 265.17 Crores Revenue with 130% PAT Increase in Q2 FY27
Sunrakshakk Industries India Limited reported its Q2 FY27 financial results with revenue of INR 265.17 crores and a profit after tax of INR 16 crores, reflecting year-on-year growth of 119.20% in revenue and 130.10% in PAT, supported by expansion in its FMCG, FMCG intermediates, and edible segments.
Read Full StoryReligare Enterprises Posts INR 4,717 Crores Income and INR 145 Crores Loss After Tax in H1 FY27, Resumes Lending and Strengthens Board
Religare Enterprises Limited has reported consolidated total income of INR 4,717 crores and a loss after tax of INR 145 crores for the half-year ending September 30, 2026, marking a 19% increase in income year-on-year. The company is transitioning from preparation to execution phase by strengthening its board with RBI-approved promoter and shareholder directors, resuming lending through Religare Finvest, and advancing growth in its core financial services and insurance businesses.
Read Full StoryBlack Box Limited Posts Record Q2 FY27 Revenue of INR 1,936 Crores and Expands Order Backlog to $1.04 Billion
Black Box Limited reported its highest-ever quarterly revenue of INR 1,936 crores for Q2 FY27, marking a 22% year-on-year increase, alongside an 88% year-on-year growth in its order backlog, which reached $1.04 billion as of September 2026. Data center order bookings crossed $250 million during H1 FY27, signaling strong momentum in hyperscale digital infrastructure projects.
Read Full Story